Bank of America Corp DE Trims Stake in GE HealthCare Technologies Inc. $GEHC

Key Points

• Bank of America reduced its GE HealthCare stake by 6.1% in the first quarter, selling 266,484 shares and retaining 4.13 million shares valued at approximately $294.2 million. Institutional investors collectively own 82.06% of the company.
• GE HealthCare reported stronger-than-expected quarterly results, with earnings of $1.13 per share and revenue of $5.29 billion, up 5.8% year over year. The company also declared a quarterly dividend of $0.035 per share.
• Analyst sentiment is mixed: the stock has a consensus “Hold” rating and a $77.73 price target, while recent insider purchases totaled 12,618 shares worth about $805,175.

Bank of America Corp DE lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 6.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,132,740 shares of the company's stock after selling 266,484 shares during the period. Bank of America Corp DE owned about 0.91% of GE HealthCare Technologies worth $294,168,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Banque Cantonale Vaudoise lifted its holdings in GE HealthCare Technologies by 16,539.1% during the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company's stock valued at $1,849,000 after purchasing an additional 25,801 shares in the last quarter. Allstate Corp increased its stake in shares of GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company's stock worth $2,681,000 after purchasing an additional 16,365 shares in the last quarter. Auto Owners Insurance Co increased its stake in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company's stock worth $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. PFA Pension Forsikringsaktieselskab acquired a new position in shares of GE HealthCare Technologies during the 4th quarter worth about $43,394,000. Finally, Boston Partners lifted its stake in GE HealthCare Technologies by 21.7% in the 4th quarter. Boston Partners now owns 4,659,562 shares of the company's stock valued at $382,223,000 after buying an additional 830,626 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $68.02 on Monday. The stock has a market cap of $30.72 billion, a PE ratio of 15.60, a P/E/G ratio of 1.97 and a beta of 0.69. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.92. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a 50-day moving average of $64.02 and a 200 day moving average of $70.43.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts' consensus estimates of $1.04 by $0.09. The business had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The business's revenue was up 5.8% on a year-over-year basis. During the same period last year, the company posted $1.06 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.91 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.21%.

Insider Buying and Selling

In related news, Director Rodney F. Hochman bought 1,618 shares of the company's stock in a transaction on Tuesday, May 12th. The stock was bought at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the acquisition, the director directly owned 1,618 shares in the company, valued at $100,364.54. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Kevin Lobo bought 10,000 shares of the business's stock in a transaction on Friday, May 22nd. The stock was bought at an average cost of $64.18 per share, with a total value of $641,800.00. Following the completion of the purchase, the director directly owned 14,363 shares in the company, valued at approximately $921,817.34. The trade was a 229.20% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have purchased 12,618 shares of company stock worth $805,175. 0.36% of the stock is owned by corporate insiders.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Better-than-expected earnings and raised guidance: GE HealthCare reported adjusted earnings of $1.13 per share, exceeding the $1.04 consensus estimate, while revenue of $5.30 billion also topped expectations. Revenue increased 5.8% year over year, and management raised its full-year EPS outlook. GE HealthCare Q2 2026 Earnings Call Summary
• Positive Sentiment: Record backlog and solid demand: Strong orders growth and a record backlog support expectations for future revenue growth and helped reinforce the bullish case for GEHC. Analysts highlighted the backlog as evidence of durable demand for the company’s medical technology and imaging products. GE HealthCare Q2 Earnings Call Highlights
• Positive Sentiment: Analyst support increased: Wells Fargo raised its price target from $75 to $85 and maintained an “overweight” rating. BTIG Research also forecast substantial appreciation, providing additional support for the shares. Wells Fargo Raises GE HealthCare Price Target
• Neutral Sentiment: Execution remains a key issue: Some analysis described demand as strong but execution as weaker, suggesting investors will watch margins, delivery performance and the company’s ability to convert its backlog into sustained earnings growth. GE HealthCare Strong Demand, Weak Execution
• Negative Sentiment: Shareholder investigations create legal uncertainty: Multiple law firms announced or continued investigations into possible securities-law violations and solicited investors who lost money. These announcements do not establish wrongdoing, but they may weigh on sentiment and raise potential litigation concerns. GEHC Securities Fraud Investigation

Analyst Ratings Changes

Several equities research analysts have commented on GEHC shares. UBS Group boosted their price objective on GE HealthCare Technologies from $67.00 to $73.00 and gave the stock a "neutral" rating in a research note on Friday. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a research report on Wednesday, April 29th. BMO Capital Markets began coverage on GE HealthCare Technologies in a research note on Wednesday, July 8th. They issued a "market perform" rating and a $70.00 price target on the stock. Hovde Group initiated coverage on GE HealthCare Technologies in a research report on Friday, July 17th. They set a "market perform" rating and a $14.00 price target for the company. Finally, Evercore reissued an "outperform" rating and issued a $84.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday. Ten research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.